Your session is about to expire
← Back to Search
Treadmill Oscillation Walking for Stroke Recovery (TOW Trial)
N/A
Recruiting
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-training, within one week after training completion, 1 month follow-up
Awards & highlights
TOW Trial Summary
This trial studies how TOW can improve walking in post-stroke individuals by improving hip and knee neuromechanical activation.
Who is the study for?
This trial is for individuals who had a stroke over 6 months ago, can stand unaided for 5 minutes, walk 10 meters with or without help, and have sufficient cognitive function. They must have more difficulty loading the affected limb during walking. Excluded are those with certain blood pressure or heart rate issues, joint replacements, severe bone/joint problems affecting gait beyond stroke effects, multiple strokes, cerebellar stroke or other major health conditions.Check my eligibility
What is being tested?
The study tests treadmill oscillation walking (TOW) to see if it improves hip and knee muscle activity and torque production in post-stroke patients. It aims to determine whether TOW can increase limb loading and walking speeds immediately after use and following a six-week program.See study design
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects of TOW may include muscle soreness or fatigue due to exercise. There might also be an increased risk of falls if balance is affected during the intervention.
TOW Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-training, within one week after training completion, 1 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-training, within one week after training completion, 1 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-efficacy
VGRF
Walking speed
TOW Trial Design
1Treatment groups
Experimental Treatment
Group I: TOWExperimental Treatment1 Intervention
Treadmill Oscillation Walking training
Find a Location
Who is running the clinical trial?
Texas State UniversityOTHER
14 Previous Clinical Trials
1,443 Total Patients Enrolled
University of Maryland, BaltimoreOTHER
688 Previous Clinical Trials
374,641 Total Patients Enrolled
University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,229 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had partial paralysis on one side due to a stroke over 6 months ago.My affected limb supports over 6% less weight than my unaffected limb when I walk.I can walk 10 meters by myself or with help.I don't have health issues preventing me from exercising, aside from my stroke.I have had one stroke affecting the surface or deep part of my brain.I have bone or joint issues that affect my walking.I have had a joint replacement in my leg.I can stand by myself for 5 minutes.I experience chest pain or shortness of breath without physical activity.I have had a stroke in the cerebellum.I have had a stroke affecting both sides of my brain or the opposite side of my previous stroke.I have had multiple strokes in the past.I can understand instructions and communicate with my doctors.I have lost half of my field of vision.I have experienced unexplained dizziness in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: TOW
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many patients are participating in this research initiative?
"Affirmative, the information on clinicaltrials.gov reveals that this experiment is recruiting participants at present. The trial was first published on December 6th 2022 and has been recently updated on December 5th 2022. Across 1 site, a total of 15 individuals are needed for enrollment in the study."
Answered by AI
Are there any vacancies for individuals to participate in this experiment?
"According to the clinicaltrials.gov platform, this research initiative is actively recruiting participants. The trial was first posted on December 6th 2022 and its details were recently updated by researchers on December 5th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger